Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CYSB2500006	注射用重组改构人肿瘤坏死因子	recombinant mutant human tumor necrosis factor	Lyophilized	Biological Products(原1)	Supplementary Application	2025-01-07		Shanghai Weike Biopharmaceutical Co Ltd			view
CYSB2500007	注射用重组改构人肿瘤坏死因子	recombinant mutant human tumor necrosis factor	Lyophilized	Biological Products(原1)	Supplementary Application	2025-01-07		Shanghai Weike Biopharmaceutical Co Ltd			view
CXSL2400910	注射用重组改构人肿瘤坏死因子	recombinant mutant human tumor necrosis factor	Lyophilized	Biological Products(3.4)	New Drug Application	2024-12-27		Guangdong Taihe Biology Pharmaceutical Co Ltd			view
CXSL2300296	注射用重组改构人肿瘤坏死因子	recombinant mutant human tumor necrosis factor	Lyophilized	Biological Products(2.2)	New Drug Application	2023-04-28		Shanghai Weike Biopharmaceutical Co Ltd			view
CYSB2101117	注射用重组改构人肿瘤坏死因子	recombinant mutant human tumor necrosis factor	Lyophilized	Biological Products	Supplementary Application	2021-07-20		Shanghai Weike Biopharmaceutical Co Ltd			view
CYSB1900375	注射用重组改构人肿瘤坏死因子	recombinant mutant human tumor necrosis factor	Lyophilized	Biological Products	Supplementary Application	2019-11-06	上海唯科生物制药有限公司	Shanghai Weike Biopharmaceutical Co Ltd	Certificate Issued	2021-01-19	view
CBSR1900001	注射用重组改构人肿瘤坏死因子	recombinant mutant human tumor necrosis factor	Lyophilized	Biological Products	State Standards	2019-04-22	广东泰禾生物药业有限公司	Guangdong Taihe Biology Pharmaceutical Co Ltd	Certificate Issued	2020-03-06	view
CXSB1800002	注射用重组改构人肿瘤坏死因子	recombinant mutant human tumor necrosis factor	Lyophilized	Biological Products	Supplementary Application	2018-02-13	广东泰禾生物药业有限公司	Guangdong Taihe Biology Pharmaceutical Co Ltd	Certificate Issued	2019-03-26	view
CYSB1700130	注射用重组改构人肿瘤坏死因子	recombinant mutant human tumor necrosis factor	Lyophilized	Biological Products	Supplementary Application	2018-01-16	上海唯科生物制药有限公司	Shanghai Weike Biopharmaceutical Co Ltd	Certificate Issued	2018-06-15	view
CXSB0800072	注射用重组改构人肿瘤坏死因子	recombinant mutant human tumor necrosis factor	Lyophilized	Biological Products	Supplementary Application	2008-11-20	上海复旦生物工程有限公司	Shanghai Fudan Bio-Engineering Co Ltd	Certificate Issued	2009-05-05	view
X0404548	注射用重组改构人肿瘤坏死因子	recombinant mutant human tumor necrosis factor	Lyophilized	Biological Products	Supplementary Application	2004-08-16	上海赛达生物药业股份有限公司	Shanghai Zhangjiang Biomedical Industry Development Co Ltd	Certificate Issued	2004-12-31	view
X0401906	注射用重组改构人肿瘤坏死因子	recombinant mutant human tumor necrosis factor	Lyophilized	Biological Products	Supplementary Application	2004-04-21	上海赛达生物药业股份有限公司	Shanghai Zhangjiang Biomedical Industry Development Co Ltd	Certificate Issued	2004-08-30	view